Activities per year
- 1 - 50 out of 98 results
Search results
-
Het afweersysteem; Werking van vaccins
Marjolein van Egmond (Speaker)
14 Jan 2021Activity: Talk or presentation › Invited talk
-
Augmented anticancer BsAb boost neutrophil cytotoxicity.
Marjolein van Egmond (Speaker)
4 Nov 2021Activity: Talk or presentation › Invited talk
-
Het afweersysteem en vaccins; Een korte uitleg in tijden van Corona
Marjolein van Egmond (Speaker)
2 Feb 2021Activity: Talk or presentation › Invited talk
-
IgA and neutrophil FcαRI: the past, present and future.
Marjolein van Egmond (Speaker)
26 Mar 2021Activity: Talk or presentation › Invited talk
-
e-seminar ‘Covid-19 vaccines'
Marjolein van Egmond (Speaker)
7 Jan 2021Activity: Talk or presentation › Invited talk
-
Augmented anticancer BsAb boost neutrophil cytotoxicity.
Marjolein van Egmond (Speaker)
11 Nov 2021Activity: Talk or presentation › Invited talk
-
Een prik; waarom zou ik
Marjolein van Egmond (Speaker)
17 Jan 2021Activity: Talk or presentation › Invited talk
-
Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity
Marjolein van Egmond (Speaker)
5 Oct 2021Activity: Talk or presentation › Invited talk
-
Openingspitch COVID-19 vaccines
Marjolein van Egmond (Speaker)
26 May 2021Activity: Talk or presentation › Invited talk
-
Het afweersysteem en vaccins; Een korte uitleg in tijden van Corona
Marjolein van Egmond (Speaker)
14 Apr 2021Activity: Talk or presentation › Invited talk
-
Immunoglobulin A: Trojan horse or magic bullet?
Marjolein van Egmond (Speaker)
9 Jan 2020Activity: Talk or presentation › Invited talk
-
Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?
Marjolein van Egmond (Speaker)
2 Feb 2020 → 7 Feb 2020Activity: Talk or presentation › Invited talk
-
Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?
Marjolein van Egmond (Speaker)
7 Feb 2020Activity: Talk or presentation › Invited talk
-
Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?
Marjolein van Egmond (Speaker)
24 Aug 2020 → 27 Aug 2020Activity: Talk or presentation › Invited talk
-
Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?
Marjolein van Egmond (Speaker)
12 Nov 2020Activity: Talk or presentation › Invited talk
-
Annals of Surgical Oncology (Journal)
Robert-Jan Coelen (Reviewer)
2020 → …Activity: Publication peer-review and editorial work › Editorial work
-
Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?
Marjolein van Egmond (Speaker)
2 Nov 2020 → 4 Nov 2020Activity: Talk or presentation › Invited talk
-
IgA in autoimmunity and in therapy.
Marjolein van Egmond (Invited speaker)
17 Jun 2019Activity: Talk or presentation › Invited talk
-
Immunoglobulin A: Trojan horse or magic bullet?
Marjolein van Egmond (Keynote speaker)
10 Dec 2019Activity: Talk or presentation › Invited talk
-
‘Targeting of the IgA Fc receptor in disease’.
Marjolein van Egmond (Invited speaker)
26 Jun 2019Activity: Talk or presentation › Invited talk
-
IgA as anti-cancer therapeutic antibodies 2.0?
Marjolein van Egmond (Invited speaker)
21 May 2019Activity: Talk or presentation › Invited talk
-
AI&II retreat
Marjolein van Egmond (Participant)
6 Jun 2019Activity: Participating in or organising an event › Organising a conference, workshop, ...
-
French National Research Agency (ANR) (External organisation)
Marjolein van Egmond (Chair)
1 Jan 2019 → 31 Dec 2019Activity: Membership › Membership of committee
-
Immunoglobulin A: Trojan horse or magic bullet?
Marjolein van Egmond (Invited speaker)
27 Aug 2019Activity: Talk or presentation › Invited talk
-
British Journal of Surgery (Journal)
Robert-Jan Coelen (Reviewer)
2019 → …Activity: Publication peer-review and editorial work › Editorial work
-
The Lancet Oncology (Journal)
Robert-Jan Coelen (Reviewer)
2019 → …Activity: Publication peer-review and editorial work › Editorial work
-
‘Immunoglobulin A: Trojan horse or magic bullet?’
Marjolein van Egmond (Invited speaker)
11 Sep 2018Activity: Talk or presentation › Invited talk
-
Keystone Symposium ‘Antibodies as Drugs: Translating Molecules into Treatments’, (Event)
M van Egmond (Chair)
2018Activity: Membership › Membership of committee
-
‘Translating antibody – effector cell cross-talk to immunotherapy’.
Marjolein van Egmond (Invited speaker)
17 Apr 2018 → 18 Apr 2018Activity: Talk or presentation › Invited talk
-
5th European Congress of Immunology
M van Egmond (Organiser)
2018Activity: Participating in or organising an event › Organising a conference, workshop, ...
-
-
Thesis committee E. Heideveld, Sanquin (External organisation)
Marjolein van Egmond (Chair)
2018Activity: Membership › Membership of committee
-
‘Enlisting myeloid effectors cells in the fight against cancer’.
M van Egmond (Invited speaker)
Jan 2018Activity: Talk or presentation › Invited talk
-
Gordon Research Conference ‘Antibody Biology and Engineering (Event)
M van Egmond (Chair)
2018Activity: Membership › Membership of committee
-
‘Translating antibody – effector cell cross-talk to immunotherapy’.
Marjolein van Egmond (Invited speaker)
25 Feb 2018 → 2 Mar 2018Activity: Talk or presentation › Invited talk
-
‘Immunoglobulin A: Trojan horse or magic bullet?’
Marjolein van Egmond (Invited speaker)
12 Sep 2018Activity: Talk or presentation › Invited talk
-
‘Immunoglobulin A: Trojan horse or magic bullet?’
M van Egmond (Invited speaker)
Jun 2018Activity: Talk or presentation › Invited talk
-
Journal of Vascular and Interventional Radiology (Journal)
Robert-Jan Coelen (Reviewer)
2018 → …Activity: Publication peer-review and editorial work › Editorial work
-
‘Immunoglobulin A: Trojan horse or magic bullet?’
Marjolein van Egmond (Invited speaker)
14 Sep 2018Activity: Talk or presentation › Invited talk
-
‘Immunoglobulin A; Trojan horse or magic bullet?’
Marjolein van Egmond (Keynote speaker)
21 Apr 2018Activity: Talk or presentation › Invited talk
-
European Phagocyte Group (External organisation)
M van Egmond (Member)
2018Activity: Membership › Membership of committee
-
‘Immunoglobulin A: Trojan horse or magic bullet?’
Marjolein van Egmond (Invited speaker)
6 Dec 2018Activity: Talk or presentation › Invited talk
-
Annals of Surgery (Journal)
Robert-Jan Coelen (Reviewer)
2017 → …Activity: Publication peer-review and editorial work › Editorial work
-
In Vitro Studies Show How To Improve The Results Of Ch/EVAR And Ch/EVAS With The Nellix Graft
JD Blankensteijn (Speaker)
14 Nov 2017Activity: Talk or presentation › Oral presentation
-
Microbubbles in thrombolysis; predicting rupture by skin biopsies.
KK Yeung (Speaker)
17 Nov 2017Activity: Talk or presentation › Oral presentation
-
Online Health Information Seeking Behavior in Patients With Upper Extremity Injury.
S Özkan (Speaker)
2 Dec 2017Activity: Talk or presentation › Oral presentation
-
Long-Term Results Of The DREAM RCT Differ From Those Of EVAR 1: EVAR Is Therefore Superior To Open Repair: Why The Difference
JD Blankensteijn (Speaker)
14 Nov 2017Activity: Talk or presentation › Oral presentation
-
Complexe Type B Dissecties.
AWJ Hoksbergen (Speaker)
14 Sep 2017Activity: Talk or presentation › Oral presentation
-
Histology of aortic aneurysms.
KK Yeung (Speaker)
19 May 2017Activity: Talk or presentation › Oral presentation
-
Preventie van littekenbreuken.
GH van Ramshorst (Speaker)
2017Activity: Talk or presentation › Oral presentation